Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.

BACKGROUND AND PURPOSE Modern radiotherapy (RT) techniques such as stereotactic RT, intensity-modulated RT, or particle irradiation allow local dose escalation with simultaneous sparing of critical organs. Several trials are currently investigating their benefit in glioma reirradiation and boost irradiation. Target volume definition is of critical importance especially when steep dose gradient techniques are employed. In this manuscript we investigate the impact of O-(2-(F-18)fluoroethyl)-l-tyrosine-positron emission tomography/computer tomography (FET-PET/CT) on target volume definition in low and high grade glioma patients undergoing either first or re-irradiation with particles. METHODS AND MATERIAL We investigated volumetric size and uniformity of magnetic resonance imaging (MRI)- vs. FET-PET/CT-derived gross tumor volumes (GTVs) and planning target volumes (PTVs) of 41 glioma patients. Clinical cases are presented to demonstrate potential benefits of integrating FET-PET/CT-planning into daily routine. RESULTS Integrating FET-uptake into the delineation of GTVs yields larger volumes. Combined modality-derived PTVs are significantly enlarged in high grade glioma patients and in case of primary RT. The congruence of MRI and FET signals for the identification of glioma GTVs is poor with mean uniformity indices of 0.39. MRI-based PTVs miss 17% of FET-PET/CT-based GTVs. Non significant alterations were detected in low grade glioma patients and in those undergoing reirradiation. CONCLUSIONS Target volume definition for malignant gliomas during initial RT may yield significantly differing results depending upon the imaging modality, which the contouring process is based upon. The integration of both MRI and FET-PET/CT may help to improve GTV coverage by avoiding larger incongruences between physical and biological imaging techniques. In low grade gliomas and in cases of reirradiation, more studies are needed in order to investigate a potential benefit of FET-PET/CT for planning of RT.

[1]  Wolfgang A Weber,et al.  An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. , 2011, International journal of radiation oncology, biology, physics.

[2]  H. Loiseau,et al.  Volumes-cibles anatomocliniques (GTV et CTV) des tumeurs gliales , 2005 .

[3]  Karl-Josef Langen,et al.  O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. , 2005, Brain : a journal of neurology.

[4]  Jean-Jacques Mazeron,et al.  Volume tumoral macroscopique (GTV) et volume–cible anatomoclinique (CTV) des tumeurs gliales de l’adulte , 2001 .

[5]  G. Jiang.  Particle therapy for cancers: a new weapon in radiation therapy , 2012, Frontiers of Medicine.

[6]  Habib Zaidi,et al.  [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma , 2008, Radiation oncology.

[7]  Oliver Jäkel,et al.  Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial , 2010, BMC Cancer.

[8]  D. Amelio,et al.  Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  If you can't see it, you can miss it: the role of biomedical imaging in radiation oncology. , 2010, Radiation protection dosimetry.

[10]  N. Laperriere,et al.  Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Hirohiko Tsujii,et al.  Particle radiation therapy using proton and heavier ion beams. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Unterberg,et al.  glioblastoma: The CLEOPATRA Trial , 2022 .

[13]  Wolfgang A Weber,et al.  PET for radiation treatment planning of brain tumours. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Kevin Petrecca,et al.  Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma , 2012, Journal of Neuro-Oncology.

[15]  Branislav Jeremic,et al.  Positron Emission Tomography for Radiation Treatment Planning , 2005, Strahlentherapie und Onkologie.

[16]  Wolfgang A Weber,et al.  11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[17]  Thomas Haberer,et al.  Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts , 2012, Radiation oncology.

[18]  D. Amelio,et al.  Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[20]  Yue Cao,et al.  Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. , 2009, International journal of radiation oncology, biology, physics.

[21]  K. Nakagawa,et al.  High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. , 1998, International journal of radiation oncology, biology, physics.

[22]  Masayuki Matsuo,et al.  Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning. , 2012, International journal of radiation oncology, biology, physics.

[23]  B. Gulyás,et al.  New PET radiopharmaceuticals beyond FDG for brain tumor imaging. , 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[24]  J. Tonn,et al.  FET-PET for malignant glioma treatment planning. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  O. Ratib,et al.  Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  Morand Piert,et al.  Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[27]  Christopher Kurz,et al.  Implementation and initial clinical experience of offline PET/CT-based verification of scanned carbon ion treatment. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  W. Curran,et al.  Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. , 2009, International journal of radiation oncology, biology, physics.

[29]  G. Stoffels,et al.  Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas , 2012, Strahlentherapie und Onkologie.

[30]  Thomas Beez,et al.  Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma , 2013, The Journal of Nuclear Medicine.

[31]  M Schwaiger,et al.  The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. , 1998, International journal of radiation oncology, biology, physics.

[32]  Branislav Jeremic,et al.  L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[33]  F. Nüsslin,et al.  High-Precision Radiation Therapy with Integrated Biological Imaging and Tumor Monitoring , 2006, Strahlentherapie und Onkologie.

[34]  J. Tonn,et al.  Therapeutic options for recurrent malignant glioma. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  M. Schwaiger,et al.  Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. , 2008, International journal of radiation oncology, biology, physics.

[36]  A. Fiorentino,et al.  Clinical target volume definition for glioblastoma radiotherapy planning: magnetic resonance imaging and computed tomography , 2013, Clinical and Translational Oncology.

[37]  H. Herzog,et al.  Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  J. Tonn,et al.  FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  M. Wannenmacher,et al.  Target volume definition in radiation therapy. , 1997, The British journal of radiology.

[40]  Katia Parodi,et al.  Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients , 2010, Acta oncologica.

[41]  H. Tsujii,et al.  l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy. , 2008, International journal of radiation oncology, biology, physics.